Navigation Links
Argentum Medical Issues Response to Recent Decision in Litigation With Noble Biomaterials
Date:3/14/2011

CHICAGO, March 14, 2011 /PRNewswire/ -- Argentum Medical, LLC today issued a response to the recent decision in their patent infringement litigation versus Noble Biomaterials, Inc.

"The most important thing to know is the trial has no impact on our patents and it is business as usual for Argentum," said Gregg Silver, Chairman and CEO of Argentum Medical, LLC. "The case concerned non-patent issues and is currently being appealed. We are confident that our appeal will be successful."

Argentum Medical is an industry leader in antimicrobial silver dressings. The company manufactures more than 60 different combinations and sizes of Silverlon® products, and has developed 14 unique categories of wound, burn and post-surgical dressings. Argentum has sold more than three million dressings to more than 2,000 customers, including the Mayo Clinic, Johns Hopkins University, University of Michigan and the Department of Defense.

This month marks Argentum Medical's 10th anniversary. The company has experienced record sales in 2010, with the Silverlon Surgical Wound Pad and Island Dressings achieving domestic sales growth of more than 300% in the second half of the year.

Silver adds, "The litigation will not affect our customers. We will continue to provide our customers with Silverlon® and our other leading products. We are a financially strong company, and service to our customers will not be affected by any expenses resulting from this lawsuit."

Argentum prides itself on groundbreaking innovation, and has particular success with its Silverlon® Negative Pressure Dressing (NPD), which was named Innovative Product of the Year by Frost and Sullivan in 2006. NPD continues to be one of the company's fastest growing categories today. It was the first antimicrobial silver dressing designed to be utilized with negative pressure wound therapy.

About Argentum Medical

Headquartered in Chicago, Illinois, Argentum Medical is a leader in antimicrobial silver dressings. In early 2001, Argentum Medical was formed to commercialize patented and patent pending silver nylon technology. With the success of its burn products, the company diversified into other areas of wound care. Today, Argentum holds over 12 patents and is the only silver wound care company to manufacture over 60 different combinations and sizes for all aspects of acute and chronic patient care. For more information, visit www.silverlon.com.


'/>"/>
SOURCE Argentum Medical, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology
2. WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
3. Sensus Healthcare Announces the Formation of a Medical Advisory Board
4. Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox
5. Aethlon Medical to Present at the Wall Street Analyst Forum 22nd Annual Investor Conference
6. Cantel Medical Acquires the Sterilization Monitoring Business of ConFirm Monitoring Systems, Inc.
7. Larta Institute NIH Success Stories Featured in 2011 California Biomedical Industry Report
8. DiaTech Oncology and Walter Reed Army Medical Center Establish Pilot to Determine Best Chemotherapy for Cancer Patients
9. Gizmox Enters the Business Mobile Application Market - Visual WebGui Based Solutions Deployed in Major Financial and Medical Institutions
10. Californias Biomedical Industry is Poised for Growth Despite Increasing Global Competition, According to the 2011 California Biomedical Industry Report
11. Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... -- Elizabeth Young and Joshua Rosenthal , PhD, of ... Health Workforce Speaker series. http://bit.ly/2lA6C8B Elizabeth ... speaking on March 9, 2017 at the Milken Institute ... at 12:00pm. The George Washington ... to examine new workforce configurations, their outcomes and associated ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... formed a strategic partnership to develop and market automated chromatographic solutions for ... automated testing solutions will save analysis time and reduce labor costs, while ...
(Date:2/28/2017)... CAMBRIDGE, Mass. and REYKJAVIK, Iceland ... WuXi AppTec group company and the contract genomics ... chief operating officer Hannes Smarason has been appointed as the ... John Long and Alex Fowkes have ... "WuXi NextCODE is executing on its vision ...
(Date:2/28/2017)... ... February 28, 2017 , ... The size and stability ... their processing and transport properties. With the Litesizer™ 100 , users can ... Litesizer™ 100 gives rapid and accurate insight into particle systems, and provides the ...
Breaking Biology Technology:
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber ... announced it has led a $3.5 million investment in  ... platform. Strategic Cyber Ventures is DC based and is ... Hank Thomas . Ron Gula , also ... Ventures, also participated in this series A round of ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
Breaking Biology News(10 mins):